Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2753835
Reference Type
Journal Article
Title
DOSE-RELATED CLASTOGENIC EFFECTS INDUCED BY BENZENE IN BONE MARROW CELLS AND IN DIFFERENTIATING SPERMATOGONIA OF SWISS CD1 MICE
Author(s)
Ciranni, R; Barale, R; Adler, ID
Year
1992
Is Peer Reviewed?
1
Journal
Mutation Research Letters
ISSN:
0165-7992
Report Number
EMIC/87163
Volume
271
Issue
2
Language
English
Abstract
TO ANSWER THE QUESTION WHETHER A GENOTOXIC CARCINOGEN MIGHT BE A GERM-CELL MUTAGEN, CYTOGENETIC DAMAGE INDUCED BY BENZENE WAS EVALUATED IN BOTH BONE MARROW CELLS (BM) AND DIFFERENTIATING SPERMATOGONIA (SPG) OF MALE SWISS CD1 MICE. THE ANALYSIS WAS PERFORMED BY DETERMINING THE FREQUENCIES OF CHROMOSOMAL ABERRATIONS IN BOTH CELL TYPES AFTER 1 ML/KG OF SINGLE BENZENE PER OS ADMINISTRATION. A WIDE RANGE OF TIMES (6, 12, 18, 24, 30, 36, 42, 48 H) WAS TESTED TO DETERMINE THE TIME OF MAXIMUM RESPONSE. THE PEAK OF MAXIMUM CLASTOGENIC EFFECT WAS FOUND 24 H AFTER TREATMENT BOTH IN BM CELLS AND IN SPG. THE CLASTOGENIC EFFECT WAS HIGHER (3-FOLD) IN BM THAN IN SPG CELLS. TWO ADDITIONAL DOSES (0.1 AND 0.5 ML/KG FOR BM; 0.25 AND 0.5 ML/KG FOR SPG) WERE TESTED TO DETERMINE THE DOSE-RESPONSE RELATIONSHIP. THE INCREASE IN ABERRANT CELLS WAS LINEAR-QUADRATIC IN BM AND LINEAR IN SPG. A QUANTITATIVE COMPARISON WAS PERFORMED BY CALCULATING THE DOUBLING DOSE (DD) FOR BOTH CELL TYPES. THE DD IS DEFINED AS THE DOSE THAT INDUCED AS MANY ABERRANT CELLS AS OCCUR SPONTANEOUSLY PER CELL GENERATION. FOR BM ONLY THE DATA FOR THE LOWER TWO DOSES WERE INCLUDED BECAUSE AT THE HIGHER DOSE THE CURVE DEVIATED FROM LINEARITY. THE DD WERE 0.25 ML/KG FOR BM AND 0.33 ML/KG FOR SPG. WE MAY REASONABLY CONCLUDE THAT BZ IS A GERM-CELL CLASTOGEN.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity